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Around the world, trypanosomatids are known for being etiological agents of several highly disabling and often fatal diseases
like Chagas disease (Trypanosoma cruzi), leishmaniasis (Leishmania spp.), and African trypanosomiasis (Trypanosoma brucei).
Throughouttheirlifecycle,theymustcopewithdiverseenvironmentalconditions,andthemechanismsinvolvedintheseprocesses
arecrucialfortheirsurvival.Inthisreview,wedescribetheroleofhemeinseveralessentialmetabolicpathwaysoftheseprotozoans.
Notwithstanding trypanosomatids lack of the complete heme biosynthetic pathway, we focus our discussion in the metabolic role
played for important heme-proteins, like cytochromes. Although several genes for diﬀerent types of cytochromes, involved in
mitochondrial respiration, polyunsaturated fatty acid metabolism, and sterol biosynthesis, are annotated at the Tritryp Genome
Project, the encoded proteins have not yet been deeply studied. We pointed our attention into relevant aspects of these protein
functions that are amenable to be considered for rational design of trypanocidal agents.
1.Introduction
Trypanosomes are parasitic protists that cause signiﬁcant
human and animal diseases worldwide [1], among which
it is important to highlight the species relevant for human
health, such as sleeping sickness or African trypanosomi-
asis (Trypanosoma brucei), Chagas’ disease or American
trypanosomiasis (Trypanosoma cruzi), and leishmaniasis
(Leishmania spp.). The life cycle of these trypanosomatids is
complex,presentingseveraldevelopmentalstagesindiﬀerent
hosts. They have developed a digenetic life cycle with one or
several vertebrate hosts and a hematophage insect vector that
allows the transmission between them. A direct consequence
is the environmental changes suﬀered among their life
cycle thus, they have to adapt their metabolism to diﬀerent
nutrient availability [2]. Another feature of these parasites
is the presence of nutritional requirements for several
essential cofactors where heme is included. They totally or
partially lack the heme biosynthetic pathway (revisited by
Koˇ ren´ y et al. [3]). Heme plays a fundamental role in many
cellular processes. It is an essential cofactor for proteins
involved in oxygen transport and storage (hemoglobin and
myoglobin), mitochondrial electron transport (Complex
II–IV), drug and steroid metabolism (cytochromes), sig-
nal transduction (nitric oxide synthases, soluble guanylate
cyclases), and transcription and regulation of antioxidant-
defense enzymes. Heme is also a regulatory molecule; its
cytosolic to nuclear ratio and the absolute amount of its
concentration aﬀects gene transcription and translation;
thus, the intracellular heme level must be tightly regulated
[4, 5]. Hence, these trypanosomatids are dependent on the
uptake of this compound from their hosts. After being
imported, heme is transported and inserted into target
heme-proteins, which are distributed throughout diﬀerent
subcellular compartments. It is not well understood how
these organisms acquire heme and how this cofactor is
distributed inside the cell. However, they contain heme-
proteins-like cytochromes, involved in essential metabolic
pathways. This review will be focused in the presence and
role of relevant heme-proteins in trypanosomatids.2 Enzyme Research
2. Heme GeneralFeatures
Heme is an essential molecule for most archaea, bacteria,
and eukaryotes. Moreover, since the growth of bacteria and
plants rely on the correct formation of tetrapyrroles, their
corresponding biosynthetic pathways are attractive targets
for antibacterial drug development and herbicide treatment
[7–9]. The free living nematode Caenorhabditis elegans lacks
the complete heme biosynthetic pathway; it feeds on bacteria
and thus has easy access to heme [10]. On the other
hand, Plasmodium falciparum, which has access to the host’s
abundant heme reservoir, is clearly dependent on its own
intrinsic heme biosynthesis [9, 11].
The heme compounds are iron-coordinated porphyrins,
speciﬁcally protoporphyrin IX (PPIX). The iron at the center
of the tetrapyrrol ring can adopt the oxidized ferric (Fe+3)
or the reduced ferrous (Fe+2) oxidation states. The majority
of the porphyrins contain iron as the central metal ion. The
most abundant heme is heme B (or protoheme), and it is
found in nearly all the heme-proteins such as hemoglobin,
myoglobin, and so forth. The tetrapyrrol structure of heme
B contains two propionate, two vinyl and four methyl side
chains (Figure 1). The oxidation of the methyl side chain to
a formyl group and the substitution of a vinyl side chain
with a 17-carbon isoprenoid side chain convert heme B
into heme A, the prosthetic group of the mitochondrial
cytochrome c oxidase and of the several bacterial terminal
oxidase. C-type hemoproteins, such as cytochrome c and
bc1 complex, contain heme c in which the two vinyl side
chains of the heme B are covalently attached to the protein
(Figure 1). For almost all organisms, hemes are essential
components of their energy recovering electron transport
chains and cofactors for several proteins. Many enzymes like
peroxidases, catalases, and the large group of cytochrome
P450 also rely on heme as a prosthetic group. Heme-proteins
can furthermore serve as sensors for diatomic gases such
as O2,C O ,a n dN Oa n df o rC O 2 in signal transduction
pathways [4].
2.1. Heme Biosynthesis. The heme biosynthetic pathway is
highly conserved through evolution [3, 12]. It is present
in most organisms but diﬀers in the synthesis of the ﬁrst
precursor, delta-aminolevulinic acid (ALA). All prokaryotes
(with the exception of α-proteobacteria) and photosynthetic
eukaryotes synthesize ALA via three consecutive enzymatic
steps starting with glutamate. The α-proteobacteria and
most nonphotosynthetic eukaryotes synthesize ALA by the
condensation of glycine with succinyl-CoA using the single
ALA-synthase enzyme (ALAS). The remaining seven steps of
the pathway (from ALA to heme B) are carried out by the
same enzymes in all organisms [12, 13].
Eukaryotes diﬀer also in the intracellular localization of
individual enzymatic steps. The photosynthetic eukaryotes
synthesizehemeexclusivelyinthechloroplasts,whileinmost
heterotrophic eukaryotes the pathway is split between the
mitochondrion and cytosol [12]( Figure 1). An interesting
case is the apicomplexan parasite because its heme synthesis
starts in the mitochondrion, then ALA is transported to
the apicoplast and the subsequent steps take place in this
specialized organelle, but the last steps appear to proceed in
the mitochondrion [14, 15].
Iron and porphyrins are highly toxic to cells, and heme
per se is a cytotoxic macrocycle with peroxidase activity.
The level of free heme inside the cell is maintained very
low, and there is a tight control of its biosynthesis based on
cellular requirements. The damaging eﬀect of heme excess
is due to iron-induced pro-oxidant eﬀect on DNA, proteins,
membrane lipids, and the cytoskeleton. The elevated level of
noniron porphyrins has been linked to harmful eﬀects; they
accumulate in membranes and can cause cellular damage
[5, 16].
2.2. Heme in Trypanosomatids. Most of the eukaryotic
organisms are able to synthesize heme and organisms with
deﬁciency in this pathway are not common. Some examples
are the anaerobic protists such as Giardia, Trichomonas, and
Entamoeba. They possess a rudimentary mitochondria-like
organelle called hydrogenosome or mitosome [18]. These
protists do not generate energy by oxidative phosphoryla-
tion, thus they do not have cytochromes and respiratory
chains. Furthermore, heme-proteins involved in oxidative
metabolism such as oxidases, peroxidases, catalases, and
hydroxylases are not needed in anaerobic conditions and
consequently they do not require heme as a cofactor [19].
But there are other organisms that even when they depend
on oxidative phosphorylation, are defective in the synthesis
of heme. Some examples are a tick [20] ;aﬁ l a r i a ln e m a t o d e
[21], the free-living nematode C. elegans [10]a n de v e n
most of the kinetoplastid parasites also belong to this
category. These organisms can aﬀord their deﬁciency in
heme synthesis due to an easy access to this compound from
their environment [21–23].
In a recently published work, Koˇ ren´ ya n dc o w o r k e r s
[3] discuss from a phylogenetic point of view the absence
of a complete heme biosynthetic pathway in Kinetoplastid
ﬂagellate organisms. These represent an interesting group of
species, where some of them lack of the complete pathway
while others possess only the last three biosynthetic steps.
The authors propose a scenario in which the ancestor of
all trypanosomatids was completely deﬁcient in the heme
synthesis. In some trypanosomatids, with the exception of
the genus Trypanosoma, the pathway was partially rescued by
genes encoding enzymes for the last three steps supposedly
obtained by horizontal transfer. On the other hand, the try-
panosomes have remained fully deﬁcient of heme synthesis
and obtain this compound from their hosts ([3]a n dr e f e r -
ences cited therein). In particular, the absence of the com-
plete heme biosynthetic pathway in T. cruzi has been pointed
out by biochemical studies [24, 25]. Later, the absence of
the genes for the enzymes involved in heme biosynthesis
in the genomes of T. cruzi and T. brucei was corroborated
when the TriTryp genomic sequence project was completed
[26, 27] (TriTrypDB, http://tritrypdb.org/tritrypdb/ [28]).
The in vitro cultivation of the mentioned Trypanosoma
requires the addition of heme compounds in the form of
hemoglobin, hematin, or hemin to the medium [29, 30].
Several other trypanosomatids including Leishmania spp.
and Crithidia fasciculata can grow in media in which heminEnzyme Research 3
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Figure 1: Schematic view of diﬀerent hemes biosynthesis pathways in S. cerevisiae. Adapted from Moraes et al. [6].4 Enzyme Research
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Figure 2: Heme biosynthesis in trypanosomatids (revisited by Koˇ ren´ ye ta l .[ 3]). Leishmania spp. can perform the last three steps in heme
synthesis, catalyzed by coproporphyrinogen oxidase, protoporphyrinogen oxidase, and ferrochelatase, localized into the mitochondria. T.
cruzi and T. brucei cannot perform any step for heme B biosynthesis and must import heme compounds (hemoglobin, hemin, etc.) from
their hosts. They can modify heme B to obtain heme A and cytochrome c, although this has been described only for T. cruzi,i ti sp r o b a b l e
that L. major and T. brucei have the same capability. Mechanisms by which these trypanosomatids couple heme to apoproteins or regulate
heme compounds levels to avoid toxic eﬀects are unknown.
is replaced by protoporphyrin IX [30–32]. This observation
provides indirect evidence that at least the last enzyme of the
pathway (ferrochelatase) remains functional. There are other
experimentaldatathatsupportthatLeishmaniaspp. presents
a partial pathway for heme biosynthesis, [31, 33, 34].
The evidence mentioned above indicates that medical
relevanttrypanosomes arecompletely(T. cruziand T. brucei)
or partially (Leishmania spp.) deﬁcient in heme synthesis, as
it is resumed in Figure 2, and they must therefore scavenge
this molecule from their hosts. Once heme is imported, it
has to be distributed inside the cell and inserted into the
target heme-proteins. As heme is a highly toxic molecule,
it is well accepted that heme carriers or chaperons involved
in its distribution exist. But, in eukaryotic cells, these type
of proteins were not reported yet [35] and the processes of
heme transport and distribution in trypanosomatids remain
unknown. Besides, these parasites present heme-proteins
involved in essential metabolic pathways like biosynthesis
of sterols and polyunsaturated fatty acids (PUFAs) carried
out in the endoplasmic reticulum (ER) and respiratory
complexes in the mitochondrion, as it is shown in Figure 3.
The understanding of how they import, distribute, utilize
heme, and assemble heme-proteins can help to elucidate the
essential metabolic pathway in these trypanosomatids.
3.Heme and Biosynthesis of
PolyunsaturatedFattyAcids andSterols
areConnectedthroughCytochromes
The precise role of heme in the proliferation as well as
diﬀerentiation of these parasites remains unknown. In the
next section, we will focus our discussion on cytochromes
and their role in lipid biosynthesis. These heme-proteins
have been scarcely studied in trypanosomatids, in spite of
being involved in a variety of key pathways. The Table 1
shows a list of genes that were annotated as cytochromes
b5, c, and P450 in the TriTrypDB, most of them assigned
by comparison of sequences but without biochemical
evidence.
3.1. Cytochrome b5: A Crucial Piece in the Fatty Acid Desatu-
ration Reaction. Fatty acid biosynthesis in trypanosomatids
has gained attention in the last few years, since endogenous
production of these compounds seems to be essential for the
parasite life cycle. A few years ago, the complete pathway for
polyunsaturated fatty acid (PUFA) synthesis in trypanoso-
matids was described [39, 40]. Indeed, it was established
that whereas L. major is able to obtain docosahexaenoic
acid (DHA, 22:6) and docosapentaenoic acid (DPA, 22:5)
from oleate, trypanosomes cannot perform this process. As
Leishmania, they produce oleate de novo, but they have to
import precursors from the hosts in order to generate DHA
and DPA. The enzymes involved in PUFAs biosynthesis are
elongases and the so-called “front end” desaturases.
A common feature of all fatty acid desaturases is the
requirement of an electron donor, ferredoxin in plastids
and bacteria, and cytochrome b5 (cytb5) in endoplasmic
reticulum [36]. In fact, cytb5 is needed not only for the
successful desaturation of fatty acids, but also for many
other oxidative reactions in the cell. It is a small heme-
binding protein that acts as an electron-transfer component
in the desaturation reaction [41], with two possible modes of
action. In the ﬁrst one, desaturation can be carried out by aEnzyme Research 5
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Figure 3: Schematic representation of transport, traﬃcking, and uses of heme in a trypanosomatid epimastigote. The ampliﬁed areas
correspond to the mitochondrial and endoplasmic reticulum regions (above and below resp.) where the heme-proteins mentioned in
the text are located. In the mitochondrion, heme B is internalized by one or several unknown transport systems. Once in the matrix (or
alternatively in the intermembrane space) heme B is transformed into heme O by the membrane-bound heme O synthase (Cox10) enzyme,
and immediately later heme O is converted into heme A by the heme A synthase (Cox15) enzyme [17]. Finally heme A is incorporated
into the cytochrome c oxidase complex by an unknown mechanism. In the endoplasmic reticulum cytochrome b5 takes electrons from
several donors, such as NADH, FADH, and other reduced compounds (not shown), and serves in turn as an electron donor for the various
transmembrane fatty acid desaturases and other ER proteins such as CYP51. Alternatively, front-end desaturases contain a cytochrome-type
domain which serves as their own electron donor. See text for more details. Abbreviations: H: heme B; HA: heme A; HO: heme O; C: c-type
cytochrome; Q: quinone; II, III, IV: complexes II, III, and IV of the electron transport chain, respectively.
multienzymatic system, which is composed by a desaturase,
NADH cytochrome b5 reductase and cytb5. The membrane-
bound cytb5 transfers electrons by lateral diﬀusion, from
NADH cytochrome b5 reductase to the desaturase [42].
In a second mode, desaturases are modular proteins that
include a cytb5 domain as a fusion either on the N-terminus
in the case of “front end” desaturases [36, 43] or on the
C-terminus in the case of fungal Δ9-desaturases [44, 45].
In addition to the desaturases, cytb5 domains have been
f o u n di nan u m b e ro fu n r e l a t e dp r o t e i n s ,s u c ha sn i t r a t e
reductases, sulﬁte oxidases, and L-lactate dehydrogenases
[45].
Desaturases may be classiﬁed as type I, II, or III [36]; as
they introduce double bonds in the middle of the carbon
chain (I), near the methyl-end (II), or at the carboxy
(front)-end (III). As mentioned above, all of them require
an electron donor, which is cytb5 in all trypanosomatids.
However, for type I and II desaturases, cytb5 acts as an
enzyme-independent component of an electron transfer
chain (with exception of fungal Δ9-desaturases); whereas
type III desaturases have these activities as a domain in the
N-terminus. In trypanosomatids, we found the three types
of desaturases, but a diﬀerent route for PUFAs biosynthesis
operates in L. major and in trypanosomes (Figure 4). L.
major contains Δ9,Δ12,ω3,Δ4, Δ5, and Δ6-desaturases
(Δ9Des,Δ12Des,ω3Des,Δ4Des,Δ5DesandΔ6Des),whereas
T. cruzi and T. brucei only contain Δ9,Δ12 and Δ4-
desaturases (Δ9Des,Δ12Des and Δ4Des). They are enzymes6 Enzyme Research
Table 1: Cytochrome genes present in L. major, T.cruzi and T. brucei. Most of the genes were annotated by similarity in Gene Bank and were
published within the TriTryp Genome Project. Only a few of them have been submitted to cloning and characterization.
Type of
cytochromes Organism Genes References
Cytb5
L. major LmjF11.0580, LmjF09.1490, LmjF36.4675,
LmjF07.0810, LmjF09.1500 (pseudogene) Ivens [34]
T. brucei Tb927.3.3470, Tb927.7.520,
Tb11.02.4485,Tb11.01.5225
Berriman et al.
[26]
T. cruzi
Tc00.1047053504431.109, Tc00.1047053508799.160,
Tc00.1047053506773.44, Tc00.1047053507951.154,
Tc00.1047053503653.60, Tc00.1047053510355.269,
Tc00.1047053509395.100, Tc00.1047053506753.110
El-Sayed et al. [27]
Cytc
L. major LmjF16.1320, LmjF16.1310 Ivens [34]
T. brucei Tb927.8.1890, Tb927.8.5120 Berriman et al.
[26]
T. cruzi Tc00.1047053511391.160, Tc00.1047053508959.4,
Tc00.1047053506949.50 El-Sayed et al. [27]
CytP450
L. major
LmjF27.0090, LmjF30.3550,
LmjF34.3330LmjF11.1100 (lanosterol 14 α demetilase,
putative)
Ivens [34]
T. brucei Tb927.3.680, Tb11.02.4080 (lanosterol 14 α
demetilase, putative)
J o u b e r te ta l .[ 37],
Berriman et al.
[26]
T. cruzi
Tc00.1047053509719.40, Tc00.1047053509231.10,
Tc00.1047053510101.50, Tc00.1047053506297.260
(lanosterol 14-alpha-demethylase, putative)
El-Sayed et al. [27]
Buckner et al. [38]
from the endoplasmic reticulum, with four or six transmem-
brane segments, as described for mouse Δ9Des [46]a n d
Δ6Des from Bacillus subtilis [47].
It is known that PUFAs accumulate at higher levels in
the parasite than in the vertebrate hosts. This behavior could
be reﬂecting a requirement for more ﬂuid membranes in
order to face with diﬀerent growth environment and/or to
be fully infective. In addition, the presence of linoleate seems
to be crucial for both procyclic and bloodstream form of T.
brucei,aswasformerlyseenforepimastigotesofT.cruzi[48].
In a recent report, linoleate synthesis was blocked by either
inhibition or RNA interference of oleate desaturase (OD, a
Δ12Des), causing a dramatic drop in parasite growth [49].
This result and the fact that mammals lack OD validate this
enzyme as a chemotherapeutic goal. Other potential targets
are “front end” desaturases since there is no evidence for the
presence of Δ4-Des in mammals. However, the relevance of
theseenzymesinthelifecycleoftheseparasitesawaitsfurther
research.
3.2. Cytochrome P450 and Its Role in Sterol Biosynthesis. The
sterols of trypanosomatids resemble those of fungi, both
in composition and biosynthesis. An important step in the
synthesis of ergosterol, an essential component of parasite
membranes,iscarriedoutbyCYP51.Thisenzymebelongsto
the cytochrome P450 (cytP450) superfamily and is a sterol-
14-α-demethylase that performs the oxidative removal of
14-alpha methyl group in lanosterol. It is localized in the
endoplasmic reticulum, probably associated by a stretch of
hydrophobic residues. CytP450 are mixed function oxidases
that catalyze the oxidation of a number of substrates. In the
case of CYP51, it has been described that it accepts electrons
from NADPH-cytP450 reductase (CPR) and from cytb5.
The role of cytb5 is to enhance the eﬃciency of the CYP51
reaction by assisting the interaction and electron transfer
between CPR and CYP51 [41].
T. cruzi and Leishmania synthesize ergosterol at all life
stages, while the bloodstream form of T. brucei is able to
import cholesterol from the host. Before the conclusion
of the Trypanosomatids Genome Project, an enzyme with
sterol-14-α-demethylase activity from T. brucei was cloned
and characterized by complementation assays in the erg11
yeast mutant cells [37]. A few years later, two alleles with
99% of identity were identiﬁed in T. cruzi, and they were
83% identical to the T. brucei protein [38]. Meanwhile,
in Leishmania there is a gene annotated as a putative
lanosterol 14-α-demethylase (LmjF11.1100) that has not
been characterized yet.
A number of antifungal azoles, inhibitors of ergosterol
biosynthesis by binding to CYP51, have been experienced
in protozoan parasites with some success. Nevertheless, the
modiﬁcation of azoles to enhance the eﬃciency and circum-
vent the potential drug resistance has been problematic due
to the lack of structural insights into the drug binding site.
Recently,theresolutionofthecrystalstructureofT.cruziand
T. brucei CYP51 cocrystallized with inhibitors (fuconazole
or posaconazole) released the opportunity to develop ratio-
nally designed anti-trypanocidal drugs [50]. Another work,Enzyme Research 7
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Figure 4: Biosynthesis of polyunsaturated fatty acids in trypanosomatids. This is an important pathway that takes place in trypanosomatids
and has been recently described [39, 40]. Cytochrome b5 operates as the electron donor for desaturation, both as an independent enzyme or
as a domain at the N-terminus of the desaturase (wildcards). Δ12, Δ15 (ω3) and Δ4-desaturases are absent from mammalian hosts and are
potential targets for trypanocidal agents.
that analyze the binding properties of a CYP51 inhibitors
library by X-ray techniques, revealed that the N-[4-pyridyl]-
formamide scaﬀold group binds in the active site of the
enzyme via conserved residues and the heme prosthetic
group.Theuseofoneofthesenonazoleinhibitorsinamouse
model of T. cruzi acute infection triggered the breakdown of
membrane parasites and the death of amastigotes [51].
4.Heme inthe Mitochondrion
Themitochondriaareoneofthemostrelevantheme-protein
containing organelles, and it includes the respiratory chain
complexes. A characteristic of these parasites is their single
and usually well-developed mitochondrion, which presents
functional and structural changes depending on the stages of
its life cycle[52].In this part of thereview,wedescribe allthe
dataavailableaboutmitochondrialhemeandcytochromesin
trypanosomatids, highlighting the similitude and diﬀerences
compared to other organisms.
4.1. Cytochrome c in Trypanosomatids—A Novel Pathway
for Cytochrome c Maturation. All eukaryotes, and almost
all prokaryotes, that use oxygen as the terminal electron
acceptor in the respiratory chain possess cytochromes c
and c1 (cytc and cytc1). The principal physiological role of
mitochondrial cytc and cytc1 is the electron transfer during
oxidative phosphorylation. These c-type cytochromes are
distinguished from other types (a and b) because heme is
covalently attached to the polypeptide via thioether bonds.
In the vast majority of the cases, heme is attached to the
protein by two thioether bonds between the heme vinyl
groups and the thiol of cysteine residues in a CXXCH motif
(heme-binding motif) (Figure 1) .T h e r ea r e ,h o w e v e r ,af e w
exceptions. One is the termed pseudo-c-type cytochrome
center in the cytochrome bf complex of thylakoids where
af o u r t hh e m ei sa t t a c h e dt ot h ec y t o c h r o m eb polypeptide
by a novel single-thioether bond [53, 54]. Also, in species
from the phylum Euglenozoa, which include the medical
relevant trypanosomatids (T. brucei, T. cruzi, and pathogenic
Leishmania spp.), heme is uniquely attached to the mito-
chondrial c-type cytochromes by a single-thioether bond
within a F/AXXCH heme binding motif [55, 56].
The cytochrome c maturation process involves the cova-
lent attachment of heme to the apocytochrome polypeptide.
Dependingonthemechanismandtheenzymesemployedfor
this posttranslational modiﬁcation, the c-type cytochromes-
containing organisms are classiﬁed into ﬁve distinct groups
(Table 2).
The system I, also known as the Ccm system (for cyto-
chrome c maturation system), is found in α-a n dγ-pro-
teobacteria, deinococci, and mitochondria of some plants
and protozoa [57]. This is well understood in Escherichia coli
[58, 59], and it is the most complex system. It consists of
eight essential proteins, named CcmA-H, and a number of8 Enzyme Research
Table 2: Diﬀerent c-type cytochromes maturation systems and examples of organisms which possess each one (in the case of eukaryotic
organisms is also denoted the organelle where the system operates) [59, 63].
System I System II System III System IV System V
E. coli
Pseudomonas
Rhizobium
Rhodobacter
Paracoccus
B. subtilis
Mycobacterium tuberculosis
Helicobacter pylori
Synechocystis
Yeast
Neurospora
C. elegans
Mouse
Human
Mitochondria
C. reinhardtii
B. subtillis (In some
oxygenic
phototrophic bacteria
and several Bacillus
spp.)
T. cruzi
T. Brucei
Leishmania spp.
C. fasciculata
Euglena gracilis
Mitochondria
Plant/Protozoa
Mitochondria Plant Chloroplasts
accessory proteins. CcmA-H are all membrane anchored or
integral membrane proteins. Heme attachment occurs in the
periplasm, after the separate translocation of heme and the
polypeptide across the plasma membrane, both synthesized
in the cytoplasm [60–62].
T h es y s t e mI Ii sl e s su n d e r s t o o dt h a ns y s t e mI ,a n di t
is the responsible for the assembly of the most complex
c-type cytochromes in which there are multiple hemes per
polypeptide chain (bacterial cytochromes). This second
system is present in Gram positive bacteria, cyanobacteria,
and some β-, δ-, and ε-proteobacteria, but also in plant and
algal chloroplasts and possibly in archea. The proteins from
system II do not share extensive sequence similarities with
representatives of system I. The system II model organism
is B. subtilis, and four proteins, ResA-C and CcdA, are
associated to it [64].
ThesystemIIIforcytochromec maturationisfoundonly
in the mitochondrial intermembrane space of some protists,
fungi and animals and the enzymes involved are heme lyases.
There are separate lyases for the attachment of heme to cytc
and cytc1 [65].
ThesystemIVhasbeendescribed forthehemelinkageto
cytochromes of the bf complex from oxygenic phototrophic
bacteria and bc complex in several Bacillus species [53, 66].
Four genes in Chlamydomonas reinhardtii,ag r e e na l g a ,
have been implicated in the covalent heme attachment to
cytochrome bf complex (associated to system IV) [62].
The scenario for cytochrome c maturation in the protist
phylum Euglenozoa seems to be totally diﬀerent from the
aforementioned systems. They contain c-type cytochromes
with a single covalent bound to the polypeptide chain
through the cysteine in the F/AXXCH motif [55, 56, 67].
Thetrypanosomatidspossesscytcandcytc1,butthereare
no recognizable proteins belonging to the c-type cytochrome
maturation systems, suggesting the presence of a distinct
mitochondrial pathway. The X-ray crystal structure of cytc
from the trypanosomatid Crithidia fasciculata was solved
[68]. It revealed that the protein folding was remarkably
similar to that of typical (CXXCH) mitochondrial cytc (in
this case cytc from yeast), including the stereochemistry of
the covalent heme attachment to the protein. The diﬀerence
appeared only in the missing thioether bond in the heme
attachmentsite.However,S.cerevisiaecytchemelyasecannot
eﬃciently mature T. brucei cytc (containing an AAQCH
heme binding motif), or a CXXCH variant, when they were
expressed in the cytoplasm of E. coli [68]. The later results let
the authors propose that a novel, yet unidentiﬁed, apparatus
for maturation of cytc operates in trypanosomatids [68].
Why the T. brucei CXXCH mutant was not able to be
maturated by the lyase (system III) is not fully clear.
Analysis of all the available genome sequences and all
publicly accessible expressed sequence tag (EST) collections
using BLAST reveal that single-cysteine attachment of heme
to mitochondrial cytc remains as a unique characteristic to
species from the phylum Euglenozoa [63]. In this scenario,
this novel system is a good candidate to be validated as a
possibletargetfordrugdesignagainstpathogenictrypanoso-
matids, in addition to expanding our understanding about
the biogenesis of heme-containing proteins.
4.2. Heme A Biosynthesis. Heme A is the essential cofactor
only for the cytochrome c oxidases (CcO, Complex IV
of the eukaryotic mitochondrial respiratory chain). It is
synthesized from heme B through two enzymatic steps
catalyzed by the heme O synthase (HOS) or Cox10 and
heme A synthase (HAS) or Cox15 enzymes (Figure 1)[ 69].
In eukaryotic cells, the heme A biosynthesis is carried
out in the mitochondria, and HOS and HAS are integral
mitochondrial inner membrane proteins [70, 71]. After
heme A is synthesized, it is inserted into the subunit I of
CcO. Defects in the maturation of heme groups that are part
of the oxidative phosphorylation system are also recognized
as important causes of diseases [6, 72, 73]. In the same way,
changes in mitochondrial heme A levels have been related to
Alzheimer’s disease [74, 75].
The presence of an active mitochondrial respiratory
chain has been demonstrated in trypanosomatids but its
metabolic dependence varies between them [52]. The blood-
stream form of T. brucei shows a rudimentary mitochon-
drion with the activity of an alternative oxidase and well-
developed glycosomes. In this case, the energetic metabolism
depends primarily on glycolysis. But the procyclic form
of T. brucei presents a well-developed mitochondrion and
less glycosomal activity [52, 76]. In T. cruzi, there is no
evidence of a mitochondrial alternative oxidase activity,
and it is proposed that this trypanosomatid depends on
the respiratory chain activity throughout the complete life
cycle. The presence of electron transport from complex IIEnzyme Research 9
to complex IV has been demonstrated, but the contribution
of complex I (NADH:ubiquinone oxidoreductase) to energy
metabolism remains controversial [77, 78].
Biochemical studies developed in T. cruzi epimastigotes
showed that the main terminal oxidase is the aa3t y p e
[79], the canonical CcO for eukaryotic cells. Additionally,
proteomic studies demonstrated the presence of subunits
of complex IV (CcO), other components of the respiratory
chain and subunits of the FoF1 ATPase (complex V) [80, 81].
Based on the evidence about the peculiar biogenesis of
cytc in trypanosomatids (discussed above), it was expected
a possible particular mechanism of heme A biosynthesis in
these organisms. However, in a recently published work by
Buchensky et al. [17], the ﬁrst functional characterization
of T. cruzi ORFs that encoded for enzymes involved in
heme A biosynthesis (named TcCox10 and TcCox15) was
presented. The sequences of these putative proteins are
conserved in others trypanosomatids. The authors showed
that the T. cruzi Cox10 and Cox15 proteins were recognized
by the yeast mitochondrial importing machinery, even
though the mitochondrial targeting sequences reported for
trypanosomatids are shorter than the ones in other cells,
including yeast [82]. These T. cruzi proteins were fully
active in the yeast mitochondria. Furthermore, the genes
encoding TcCox10 and TcCox15 (TcCOX10 and TcCOX15)
were diﬀerentially transcribed during the parasite life cycle.
The authors postulate that the observed changes in the
mRNA levels of TcCOX10 and TcCOX15 could be a form of
regulation reﬂecting diﬀerences in respiratory requirements
at diﬀerent life stages.
It is important to note that, once heme is in the
mitochondrion, it could be inserted in diﬀerent mito-
chondrial heme-proteins. How heme is transported to the
mitochondrion and how it is imported by the mitochondrial
membranes to be used in this organelle are still open
questions, since carriers, chaperons, and transporters have
not been identiﬁed yet. Based on the evidences discussed
here, while cytochrome c biogenesis could proceed from a
novel and characteristic mechanism, apparently restricted to
Euglenophyta, the heme A biosynthesis might be synthesized
by conserved enzymatic pathways.
5. Concluding Remarks
Trypanosomatids are under varying nutritional pressures
during their life cycles; consequently, they must adapt
their metabolism to diﬀerent environments. These para-
sites display auxotrophies for various cofactors, including
heme. Heme biosynthesis is absent from trypanosomes, and
although L. major possesses the last three enzymes of the
pathway, it still needs to import precursors from the host.
From what we know up to now, a few points in which
diﬀerences between parasites and hosts might be exploited
for rational design of therapeutic compounds exist, for
instance, the novel system for maturation of cytochromes c,
which does not match to any other known system, and the
role of cytochromes b5 as electron donors in at least two
essential pathways (PUFAs and ergosterol biosynthesis).
However,inspiteoftheconclusionofthegenomeproject
forTriTryp,thereareanumberofunknownaspectsthatneed
furtherresearch.Itisnotclear,forexample,howhemegroup
is internalized into the cell and how it is coupled to heme-
proteins. Also it is not known how diﬀerent cytochromes
reach their ﬁnal intracellular location: mitochondria (cytc)
and endoplasmic reticulum (cytb5, CYP51) and how cytb5
is organized in the membrane in order to fulﬁll its role as
electron donor for diverse anchored enzymes. New insights
into these and other aspects of heme and cytochromes
functions would shed light into vital biological processes
from these protozoan organisms that could be potential
therapeutic targets.
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